Jonathan L Thornsberry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 E. Route 66, Strafford, MO 65757 Phone: 417-736-9175 Fax: 417-736-9178 |
Dr. Shawnie S. Replogle, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 363 East Route 66, Strafford, MO 65757 Phone: 417-736-9175 Fax: 417-736-9178 |
News Archive
Researchers reported today that SolirisĀ® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.
The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.
GoDaddy.com, the world's largest provider of Web hosting and domain name registrations, is donating $10,000 to help cancer patients and kick-start fundraising for the 4th annual Scottsdale Healthcare Rob Moy Memorial Motorcycle Run.
In an Acta Neurologica Scandinavia study of 182 patients with Parkinson's disease and 185 healthy controls, patients with Parkinson's disease had significantly lower levels of vitamin D in their blood.
› Verified 4 days ago